ATE182007T1 - Bestimmung der kompatibilität anhand von löslichem hla - Google Patents

Bestimmung der kompatibilität anhand von löslichem hla

Info

Publication number
ATE182007T1
ATE182007T1 AT92912658T AT92912658T ATE182007T1 AT E182007 T1 ATE182007 T1 AT E182007T1 AT 92912658 T AT92912658 T AT 92912658T AT 92912658 T AT92912658 T AT 92912658T AT E182007 T1 ATE182007 T1 AT E182007T1
Authority
AT
Austria
Prior art keywords
hla
antibodies
human
recipient
donor
Prior art date
Application number
AT92912658T
Other languages
English (en)
Inventor
Philippe Pouletty
Original Assignee
Sangstat Medical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sangstat Medical Corp filed Critical Sangstat Medical Corp
Application granted granted Critical
Publication of ATE182007T1 publication Critical patent/ATE182007T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
AT92912658T 1991-06-05 1992-05-28 Bestimmung der kompatibilität anhand von löslichem hla ATE182007T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/710,710 US5223397A (en) 1991-06-05 1991-06-05 Soluble hla cross-match

Publications (1)

Publication Number Publication Date
ATE182007T1 true ATE182007T1 (de) 1999-07-15

Family

ID=24855193

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92912658T ATE182007T1 (de) 1991-06-05 1992-05-28 Bestimmung der kompatibilität anhand von löslichem hla

Country Status (9)

Country Link
US (1) US5223397A (de)
EP (1) EP0588903B1 (de)
JP (1) JPH06508687A (de)
AT (1) ATE182007T1 (de)
CA (1) CA2103151A1 (de)
DE (1) DE69229553T2 (de)
DK (1) DK0588903T3 (de)
ES (1) ES2136089T3 (de)
WO (1) WO1992021978A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5482841A (en) * 1994-05-24 1996-01-09 Sangstat Medical Corporation Evaluation of transplant acceptance
US5785966A (en) * 1994-06-15 1998-07-28 Coles; John G. Inhibition of human xenogenic or allogenic antibodies to reduce xenograft or allograft rejection in human recipients
IT1271593B (it) * 1994-11-30 1997-06-04 Sanitaria Scaligera Spa Procedimento ed apparecchiatura per l'immunoadsorbimento specifico di virus hiv, di antigene gp120 e complesso cd4-gp120.
US5948627A (en) 1997-05-30 1999-09-07 One Lambda Immunobead flow cytometric detection of anti-HLA panel-reactive antibody
US6046013A (en) * 1997-08-01 2000-04-04 Gti Process for identifying specific antibodies associated with HLA
US8680059B2 (en) * 1998-05-20 2014-03-25 Biotempt B.V. Oligopeptide acetate and formulations thereof
US6844315B2 (en) 1998-05-20 2005-01-18 Erasmus Universiteit Rotterdam Immunoregulator
US20050227925A1 (en) * 2004-04-08 2005-10-13 Robbert Benner Compositions capable of reducing elevated blood urea concentration
US20030220258A1 (en) * 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
US20040202645A1 (en) * 2003-04-08 2004-10-14 Khan Nisar Ahmed Administration of gene-regulatory peptides
US6921751B1 (en) * 1998-05-20 2005-07-26 Erasmus Universiteit Rotterdam Immunoregulator
US8088586B2 (en) * 2000-03-17 2012-01-03 Oxford Radcliffe Hospital Nhs Trust Method of producing a body fluid sample depleted of anti-MHC antibodies
US8609436B2 (en) * 2000-03-17 2013-12-17 Guy's & St Thomas' Hospital NHS Trust (“GST”) Method
US7358330B2 (en) * 2001-03-29 2008-04-15 Biotempt B.V. Immunoregulatory compositions
EP1300418A1 (de) * 2001-10-04 2003-04-09 Erasmus Universiteit Rotterdam Genregulation durch Oligopeptide
US20040013661A1 (en) * 2001-12-21 2004-01-22 Gert Wensvoort Stratification
US20030220257A1 (en) * 2001-12-21 2003-11-27 Robbert Benner Treatment of trauma
US20030224995A1 (en) * 2001-12-21 2003-12-04 Khan Nisar Ahmed Treatment of burns
US7786084B2 (en) * 2001-12-21 2010-08-31 Biotempt B.V. Treatment of burns
US7560433B2 (en) 2001-12-21 2009-07-14 Biotempt B.V. Treatment of multiple sclerosis (MS)
US7501391B2 (en) * 2001-12-21 2009-03-10 Biotempt B.V. Treatment of transplant survival
US20030220260A1 (en) * 2001-12-21 2003-11-27 Khan Nisar Ahmed Peptide compositions
US20080242837A1 (en) * 2001-12-21 2008-10-02 Khan Nisar A Peptide compositions
US20080318871A1 (en) * 2001-12-21 2008-12-25 Khan Nisar A Treatment of neurological disorders
US20030220261A1 (en) * 2001-12-21 2003-11-27 Khan Nisar Ahmed Treatment of iatrogenic disease
US20040241764A1 (en) * 2003-06-02 2004-12-02 Uri Galili Early detection of recipient's immune response against heart transplant
US20090227505A1 (en) * 2004-01-07 2009-09-10 Biotempt B.V. Methods and uses for protein breakdown products
JP4846799B2 (ja) * 2005-07-05 2011-12-28 バイオテンプト ベー．フェー． 腫瘍の治療
EP1864692A1 (de) * 2006-06-07 2007-12-12 Biotempt B.V. Verwendung von peptiden zum Schutz von Strahlenschäden
DK2120991T3 (da) * 2007-02-12 2014-04-28 Biotempt Bv Behandling af traumatisk blødning med korte oligopeptider
WO2010065425A1 (en) 2008-12-01 2010-06-10 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for detection of complement fixing antibodies
US10101337B2 (en) 2013-03-14 2018-10-16 The Board Of Trustees Of The Leland Stanford Junior University Methods of detecting donor-specific antibodies and systems for practicing the same
US20170082619A1 (en) 2015-09-23 2017-03-23 One Lambda, Inc. Methods of Detecting Alloantibodies Using HLA and Non-HLA Antigens
US10527613B2 (en) 2015-11-10 2020-01-07 The Board Of Trustees Of The Leland Stanford Junior University Biomarker detection methods and systems and kits for practicing same
CN109283037A (zh) * 2018-09-03 2019-01-29 万峰春 一种交叉配型检验装置

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE68524T1 (de) * 1985-07-09 1991-11-15 Quadrant Bioresources Ltd Beschuetzung von proteinen und aehnlichem.
US4895706A (en) * 1986-10-28 1990-01-23 Costar Corporation Multi-well filter strip and composite assemblies
US4810632A (en) * 1986-12-01 1989-03-07 Scripps Clinic And Research Foundation Cell surface antigen detection method
US4959308A (en) * 1987-08-27 1990-09-25 Board Of Regents, The University Of Texas System Immunoassay for antibodies binding platelets

Also Published As

Publication number Publication date
DK0588903T3 (da) 2000-01-24
EP0588903A4 (en) 1994-06-29
EP0588903A1 (de) 1994-03-30
EP0588903B1 (de) 1999-07-07
US5223397A (en) 1993-06-29
WO1992021978A1 (en) 1992-12-10
DE69229553T2 (de) 1999-11-25
DE69229553D1 (de) 1999-08-12
JPH06508687A (ja) 1994-09-29
CA2103151A1 (en) 1992-12-06
ES2136089T3 (es) 1999-11-16

Similar Documents

Publication Publication Date Title
ATE182007T1 (de) Bestimmung der kompatibilität anhand von löslichem hla
MY104946A (en) Antigen antibody conjugate.
NO980030D0 (no) Monoklonale antistoffer som binder CD40-L
DE58902586D1 (de) Immunoassay und -rolymere igg-derivate zur kompensation von stoerfaktoren in immunoassays.
AU4975090A (en) Mitomycin c derivatized with a hapten
ES2091202T3 (es) Composicion y metodos para determinar la presencia de anfetaminas en una muestra de la que se sospecha que contiene anfetamina y/o metanfetamina.
AU6839090A (en) Hepatitis c assay
DE3584035D1 (de) Nachweis von menschlichem cytomegalovirus-spezifischem igm.
AU619183B2 (en) A one-step immunoassay for the determination of antigen-specific antibodies of one of the immunoglobulin classes a,m,d or e, and an agent suitable for this purpose
DK0378175T3 (da) Diagnostisk påvisning under anvendelse af kimære antistoffer
GB2255637B (en) Separation method
FI884505A7 (fi) Immunoanalyysi, jossa käytetään IgG-sieppaajavasta-ainetta ja monen monoklonaalisen vasta-aineen osoitusjärjestelmä.
TW222686B (de)
DE69200460D1 (de) Agglutinationskomplex zum Nachweis von Blutgruppen.
DK101196A (da) Histaminderivat, histamin-immunogen-konjugat samt antistof fremstillet mod konjugatet
GR920100123A (el) Αντιδραστήριο πολυχρωματικής κηλίδωσης και μέ?οδος ανάλυσης.
AU5456186A (en) Detection of human T-cell leukemia virus type III
ES2084581T3 (es) Inmunoensayos que utilizan antigenos producidos en organismos hetereologicos.
NO890116D0 (no) Monoklonale antistoffer.
AU3829189A (en) Detecting antigens or antibodies
DE68910956D1 (de) Mit toxin modifizierter antikörper.
NO870461D0 (no) Reagens for paavisning av antistoff mot virusantigener.
FI893928A7 (fi) Monoklonala motkroppar.
DK0558361T3 (da) Sensibiliserede erythrocytter, fremgangsmåde til fremstilling heraf og anvendelse heraf
NO903788D0 (no) Monoklonalt antistoff mot protein c.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee